A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
for
Nasal Polyps
Location: Plano TX
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07782957
Phase3, Recruiting
New
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
for
Parkinson's Disease (PD), Healthy Control Subjects
Location: New Haven CT
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Sex: All
Age: 18+
Code: NCT07830654
Phase2, Recruiting
Active & ResponsiveNew
Remote Monitoring Using a Digital Platform
for
Chronic Pain
Location: Hackensack NJ, Paramus NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 18+
Code: NCT07837102
Recruiting
Active & ResponsiveNew
Ancillary Nocturnal Urinary Symptoms Analyses for TRIUMPH
for
Nocturia
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: Female
Age: 60+
Code: NCT07829029
Recruiting
New
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
for
Colorectal Cancer (Locally Advanced or Metastatic)
Location: Faifax VA, Houston TX
Sponsor: SOTIO Biotech a.s.
Sex: All
Age: 18+
Code: NCT07693751
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: Foxborough MA, The Bronx NY, Yardley PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07783802
Phase2, Recruiting
New
RESvEraTrol in Parkinson's Disease (RESET)
for
Parkinson's Disease
Location: Washington D.C. DC
Sponsor: Georgetown University
Sex: All
Age: 55 - 70+
Code: NCT07592767
Phase2, Recruiting
Active & ResponsiveNew
A Study of DS3610a in Participants With Advanced Solid Tumor
for
Solid Tumors, Metastatic Solid Tumors
Location: Milwaukee WI
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07159126
Phase1, Recruiting
New
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
for
Multiple Myeloma
Location: Hackensack NJ, Washington D.C. DC
Sponsor: Hackensack Meridian Health
Sex: All
Age: 18+
Code: NCT04661137
Phase2, Recruiting
New
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
for
Subcutaneous Fat
Location: New York NY, Hunt Valley MD, Baton Rouge LA, Omaha NE,
Sponsor: Caliway Biopharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT07140939
Phase3, Recruiting
New
Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
for
Hepatocellular Carcinoma (HCC)
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 18+
Code: NCT07027436
Phase3, Recruiting
New
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia
Location: Fredericksburg VA, Peoria IL, Long Beach CA
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07700238
Phase3, Recruiting
New
Fall Prevention Pathways
for
Old Age; Debility
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 65 - 70+
Code: NCT07824141
Recruiting
Active & ResponsiveNew
Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
for
PARKINSON DISEASE (Disorder)
Location: Richardson TX
Sponsor: The University of Texas at Dallas
Sex: All
Age: 50 - 70+
Code: NCT07534397
Recruiting
New
Clinical Evaluation of an Airborne Pathogen Containment Device: Randomized Open-label Equivalence Trial During Endotracheal Intubation